Evidence map›Paper›PMID 29127235›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2018

Cardiac performance is limited by oxygen delivery to the mitochondria in the crystalloid-perfused working heart.

Sarah Kuzmiak-Glancy, Raúl Covian, Armel N Femnou, Brian Glancy, Rafael Jaimes, Anastasia M Wengrowski, Kara Garrott, Stephanie A French, Robert S Balaban, Matthew W Kay

Open access · bronzeAbstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 33 citations in OpenAlex.

  1. A Beginner's Guide to Cardiac Optical Mapping.Cardiovascular engineering and technology · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Mechanisms of reduced myocardial energetics of the dystrophic heart.American journal of physiology. Heart and circulatory physiology · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Guidelines for assessment of cardiac electrophysiology and arrhythmias in small animals.American journal of physiology. Heart and circulatory physiology · 2022
    Review
  13. Article
  14. Diabetic Cardiomyopathy: Pathophysiology and Novel Therapies.The Brown journal of hospital medicine · 2022
    Review
  15. Stop the beat to see the rhythm: excitation-contraction uncoupling in cardiac research.American journal of physiology. Heart and circulatory physiology · 2021
    Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Sarah Kuzmiak-GlancyDepartment of Biomedical Engineering, The George Washington University , Washington, District of Columbia.
Raúl CovianLaboratory of Cardiac Energetics, National Heart, Lung, and Blood Institute, National Institutes of Health , Bethesda, Maryland.
Armel N FemnouDepartment of Biomedical Engineering, The George Washington University , Washington, District of Columbia.
Brian GlancyLaboratory of Cardiac Energetics, National Heart, Lung, and Blood Institute, National Institutes of Health , Bethesda, Maryland.
Rafael JaimesDepartment of Biomedical Engineering, The George Washington University , Washington, District of Columbia.
Anastasia M WengrowskiDepartment of Biomedical Engineering, The George Washington University , Washington, District of Columbia.
Kara GarrottDepartment of Biomedical Engineering, The George Washington University , Washington, District of Columbia.
Stephanie A FrenchLaboratory of Cardiac Energetics, National Heart, Lung, and Blood Institute, National Institutes of Health , Bethesda, Maryland.
Robert S BalabanLaboratory of Cardiac Energetics, National Heart, Lung, and Blood Institute, National Institutes of Health , Bethesda, Maryland.
Matthew W KayDepartment of Biomedical Engineering, The George Washington University , Washington, District of Columbia.
George Washington University · USNational Institutes of Health · USNational Heart Lung and Blood Institute · US

Funding

NHLBI Animal Program DivisionZIGHL006020 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI CLARK, TANNIA · 2009 to 2025
$47.3M
Control Of Cellular Energy MetabolismZIAHL004601 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI BALABAN, ROBERT · 2009 to 2023
$24.4M
Development and Regulation of the Muscle Mitochondrial ReticulumZIAHL006221 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI GLANCY, BRIAN · 2017 to 2025
$14.7M
Low flow reperfusion after acute myocardial ischemia: when too little is too muchR01HL095828 · NHLBI · GEORGE WASHINGTON UNIVERSITY · PI KAY, MATTHEW W. · 2010 to 2014
$1.6M
Oxygen-rich perfusate that is compatible with optical assessments of myocardial physiologyR21HL132618 · NHLBI · GEORGE WASHINGTON UNIVERSITY · PI KAY, MATTHEW W. · 2016 to 2017
$406k
NHLBI NIH HHS R01 HL095828NHLBI NIH HHS R21 HL132618
6 · The paper itself

Abstract

The left ventricular working, crystalloid-perfused heart is used extensively to evaluate basic cardiac function, pathophysiology, and pharmacology. Crystalloid-perfused hearts may be limited by oxygen delivery, as adding oxygen carriers increases myoglobin oxygenation and improves myocardial function. However, whether decreased myoglobin oxygen saturation impacts oxidative phosphorylation (OxPhos) is unresolved, since myoglobin has a much lower affinity for oxygen than cytochrome c oxidase (COX). In the present study, a laboratory-based synthesis of an affordable perfluorocarbon (PFC) emulsion was developed to increase perfusate oxygen carrying capacity without impeding optical absorbance assessments. In left ventricular working hearts, along with conventional measurements of cardiac function and metabolic rate, myoglobin oxygenation and cytochrome redox state were monitored using a novel transmural illumination approach. Hearts were perfused with Krebs-Henseleit (KH) or KH supplemented with PFC, increasing perfusate oxygen carrying capacity by 3.6-fold. In KH-perfused hearts, myoglobin was deoxygenated, consistent with cytoplasmic hypoxia, and the mitochondrial cytochromes, including COX, exhibited a high reduction state, consistent with OxPhos hypoxia. PFC perfusate increased aortic output from 76 ± 6 to 142 ± 4 ml/min and increased oxygen consumption while also increasing myoglobin oxygenation and oxidizing the mitochondrial cytochromes. These results are consistent with limited delivery of oxygen to OxPhos resulting in an adapted lower cardiac performance with KH. Consistent with this, PFCs increased myocardial oxygenation, and cardiac work was higher over a wider range of perfusate Po

Indexed as

AnimalsCrystalloid SolutionsCytochromes cEmulsionsFluorocarbonsGlucoseHeartIsolated Heart PreparationMitochondria, HeartMyocardial ContractionMyoglobinOxidation-ReductionOxidative PhosphorylationOxygenOxygen ConsumptionPerfusionCrystalloid SolutionsCytochromes cEmulsionsFluorocarbonsGlucoseKrebs-Henseleit solutionMyoglobinOxygenTromethaminecytochrome c oxidasemyoglobin oxygen saturationoxidative phosphorylationrabbitrapid-scanning optical spectroscopy

Identifiers

PMID29127235
PMCPMC5966767
OpenAlexW2767450615

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.